JP2005536229A5 - - Google Patents

Download PDF

Info

Publication number
JP2005536229A5
JP2005536229A5 JP2004545233A JP2004545233A JP2005536229A5 JP 2005536229 A5 JP2005536229 A5 JP 2005536229A5 JP 2004545233 A JP2004545233 A JP 2004545233A JP 2004545233 A JP2004545233 A JP 2004545233A JP 2005536229 A5 JP2005536229 A5 JP 2005536229A5
Authority
JP
Japan
Prior art keywords
oligonucleotide
hybridization
dna
analyzing
nucleic acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2004545233A
Other languages
English (en)
Japanese (ja)
Other versions
JP2005536229A (ja
Filing date
Publication date
Priority claimed from US10/215,890 external-priority patent/US20040029121A1/en
Priority claimed from US10/281,076 external-priority patent/US20040029128A1/en
Application filed filed Critical
Publication of JP2005536229A publication Critical patent/JP2005536229A/ja
Publication of JP2005536229A5 publication Critical patent/JP2005536229A5/ja
Withdrawn legal-status Critical Current

Links

JP2004545233A 2002-08-08 2003-08-08 カルシトニン遺伝子関連ＣｐＧジヌクレオチドのメチル化状態分析のための方法および核酸 Withdrawn JP2005536229A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US10/215,890 US20040029121A1 (en) 2002-08-08 2002-08-08 Methods and nucleic acids for the analysis of CpG dinucleotide methylation status associated with the calcitonin gene
US10/281,076 US20040029128A1 (en) 2002-08-08 2002-10-25 Methods and nucleic acids for the analysis of CpG dinucleotide methylation status associated with the calcitonin gene
PCT/US2003/025044 WO2004035806A2 (en) 2002-08-08 2003-08-08 Methods and nucleic acids for the analysis of cpg dinucleotide methylation status associated with the calcitonin gene

Publications (2)

Publication Number Publication Date
JP2005536229A JP2005536229A (ja) 2005-12-02
JP2005536229A5 true JP2005536229A5 (enExample) 2006-07-27

Family

ID=32109763

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2004545233A Withdrawn JP2005536229A (ja) 2002-08-08 2003-08-08 カルシトニン遺伝子関連ＣｐＧジヌクレオチドのメチル化状態分析のための方法および核酸

Country Status (5)

Country Link
US (1) US20040029128A1 (enExample)
EP (1) EP1576190A4 (enExample)
JP (1) JP2005536229A (enExample)
AU (1) AU2003298546A1 (enExample)
WO (1) WO2004035806A2 (enExample)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20110151438A9 (en) 2001-11-19 2011-06-23 Affymetrix, Inc. Methods of Analysis of Methylation
US20050233340A1 (en) * 2004-04-20 2005-10-20 Barrett Michael T Methods and compositions for assessing CpG methylation
EP2290071B1 (en) 2004-05-28 2014-12-31 Asuragen, Inc. Methods and compositions involving microRNA
EP2314688B1 (en) 2004-11-12 2014-07-16 Asuragen, Inc. Methods and compositions involving miRNA and miRNA inhibitor molecules
US20060292585A1 (en) * 2005-06-24 2006-12-28 Affymetrix, Inc. Analysis of methylation using nucleic acid arrays
US7901882B2 (en) 2006-03-31 2011-03-08 Affymetrix, Inc. Analysis of methylation using nucleic acid arrays
US8084734B2 (en) * 2006-05-26 2011-12-27 The George Washington University Laser desorption ionization and peptide sequencing on laser induced silicon microcolumn arrays
AU2007299828C1 (en) * 2006-09-19 2014-07-17 Interpace Diagnostics, Llc MicroRNAs differentially expressed in pancreatic diseases and uses thereof
JP2010510964A (ja) * 2006-09-19 2010-04-08 アシュラジェン インコーポレイテッド 治療的介入の標的としての、ｍｉＲ−１５、ｍｉＲ−２６、ｍｉＲ−３１、ｍｉＲ−１４５、ｍｉＲ−１４７、ｍｉＲ−１８８、ｍｉＲ−２１５、ｍｉＲ−２１６、ｍｉＲ−３３１、ｍｍｕ−ｍｉＲ−２９２−３ｐによって調節される遺伝子および経路
CN101622350A (zh) * 2006-12-08 2010-01-06 奥斯瑞根公司 作为干预治疗靶标的miR-126调控基因和通路
CA2671299A1 (en) * 2006-12-08 2008-06-19 Asuragen, Inc. Functions and targets of let-7 micro rnas
CA2671294A1 (en) * 2006-12-08 2008-06-19 Asuragen, Inc. Mir-21 regulated genes and pathways as targets for therapeutic intervention
US20090175827A1 (en) * 2006-12-29 2009-07-09 Byrom Mike W miR-16 REGULATED GENES AND PATHWAYS AS TARGETS FOR THERAPEUTIC INTERVENTION
US20090232893A1 (en) * 2007-05-22 2009-09-17 Bader Andreas G miR-143 REGULATED GENES AND PATHWAYS AS TARGETS FOR THERAPEUTIC INTERVENTION
US20090131354A1 (en) * 2007-05-22 2009-05-21 Bader Andreas G miR-126 REGULATED GENES AND PATHWAYS AS TARGETS FOR THERAPEUTIC INTERVENTION
WO2008154333A2 (en) * 2007-06-08 2008-12-18 Asuragen, Inc. Mir-34 regulated genes and pathways as targets for therapeutic intervention
WO2009036332A1 (en) 2007-09-14 2009-03-19 Asuragen, Inc. Micrornas differentially expressed in cervical cancer and uses thereof
WO2009052386A1 (en) * 2007-10-18 2009-04-23 Asuragen, Inc. Micrornas differentially expressed in lung diseases and uses thereof
WO2009070805A2 (en) * 2007-12-01 2009-06-04 Asuragen, Inc. Mir-124 regulated genes and pathways as targets for therapeutic intervention
WO2009086156A2 (en) * 2007-12-21 2009-07-09 Asuragen, Inc. Mir-10 regulated genes and pathways as targets for therapeutic intervention
US20090263803A1 (en) * 2008-02-08 2009-10-22 Sylvie Beaudenon Mirnas differentially expressed in lymph nodes from cancer patients
WO2009111643A2 (en) * 2008-03-06 2009-09-11 Asuragen, Inc. Microrna markers for recurrence of colorectal cancer
WO2009154835A2 (en) * 2008-03-26 2009-12-23 Asuragen, Inc. Compositions and methods related to mir-16 and therapy of prostate cancer
EP2285960B1 (en) 2008-05-08 2015-07-08 Asuragen, INC. Compositions and methods related to mir-184 modulation of neovascularization or angiogenesis
WO2010056737A2 (en) * 2008-11-11 2010-05-20 Mirna Therapeutics, Inc. Methods and compositions involving mirnas in cancer stem cells
US8110796B2 (en) 2009-01-17 2012-02-07 The George Washington University Nanophotonic production, modulation and switching of ions by silicon microcolumn arrays
US9490113B2 (en) * 2009-04-07 2016-11-08 The George Washington University Tailored nanopost arrays (NAPA) for laser desorption ionization in mass spectrometry
WO2013040251A2 (en) 2011-09-13 2013-03-21 Asurgen, Inc. Methods and compositions involving mir-135b for distinguishing pancreatic cancer from benign pancreatic disease
JP2021112127A (ja) * 2018-04-26 2021-08-05 暁生 黒田 膵β細胞の傷害検査方法
KR102728009B1 (ko) * 2022-10-28 2024-11-08 주식회사 비츠로셀 고온 특성이 향상된 이온전도성 전구체 전해액 및 이를 포함하는 에너지 저장 장치

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU7829398A (en) * 1997-06-09 1998-12-30 University Of Southern California A cancer diagnostic method based upon dna methylation differences
US20040029123A1 (en) * 2000-03-15 2004-02-12 Alexander Olek Diagnosis of diseases associated with the cell cycle
AU2001277521A1 (en) * 2000-06-30 2002-01-14 Epigenomics Ag Diagnosis of diseases associated with cell signalling
EP1340818A1 (en) * 2002-02-27 2003-09-03 Epigenomics AG Method and nucleic acids for the analysis of a colon cell proliferative disorder
WO2004020662A2 (en) * 2002-08-27 2004-03-11 Epigenomics Ag Method and nucleic acids for the analysis of breast cell proliferative disorders

Similar Documents

Publication Publication Date Title
JP2005536229A5 (enExample)
Garrigan et al. Evidence for archaic Asian ancestry on the human X chromosome
Biswas et al. Genome wide characterization of short tandem repeat markers in sweet orange (Citrus sinensis)
ATE516371T1 (de) Oligonukleotide und deren verwendungen
WO2006031745A3 (en) Methods for long-range sequence analysis of nucleic acids
JP2017532042A5 (enExample)
JP2010525813A5 (enExample)
WO2004033649A3 (en) High throughput multiplex dna sequence amplifications
ATE414177T1 (de) Oligonukleotide zur genotypisierung des thymidylat-synthase gens
CA2528577A1 (en) Methods and compositions for whole genome amplification and genotyping
WO2005049851A3 (en) Methods, articles, and compositions for identifying oligonucleotides
WO2004039953A3 (en) Array oligomer synthesis and use.
WO2007131135A3 (en) Evaluating genetic disorders
JP2017519774A5 (enExample)
JP2007537751A5 (enExample)
RU2013118722A (ru) Прямой захват, амплификация и секвенирование днк-мишени с использованием иммобилизированных праймеров
GEP20125384B (en) Representations of nucleotide sequences
WO2007130519A3 (en) Viral nucleic acid microarray and method of use
DE60018052D1 (de) Vergleichende fluoreszenz-hybridisierung auf oligonukleotid mikroarrays
WO2009064973A4 (en) Diagnostic kits and methods for scd or sca therapy selection
JP2002525127A5 (enExample)
JP2003219893A5 (enExample)
EP2730663A3 (en) Genetic factors associated with inhibitor development in hemophilia A
CN105431555A (zh) 用于亚硫酸氢盐转化的序列捕获的组合物和方法
JP2003325191A5 (enExample)